Large-scale isolation of CD34+ cells using the Amgen cell selection device results in high levels of purity and recovery.
about
Monocyte-derived CXCL7 peptides in the marrow microenvironmentAutologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cellsCirculating Tumor Cell Isolation and Analysis.Use of CD34+ autologous stem cell transplantation in the treatment of children with refractory systemic lupus erythematosus.G-CSF-mobilized haploidentical peripheral blood stem cell transplantation in children with poor prognostic nonmalignant disorders.Clinical applications of CD34(+) peripheral blood progenitor cells (PBPC).Progress in haematopoietic stem cell transplantation for multiple myeloma.Partially matched transplants with allogeneic CD34+ blood cells.Molecular genetic analysis of orf virus: a poxvirus that has adapted to skinPurging peripheral blood progenitor cell grafts from lymphoma cells: quantitative comparison of immunomagnetic CD34+ selection systems.The removal of human breast cancer cells from hematopoietic CD34+ stem cells by dielectrophoretic field-flow-fractionation.CTC clusters in cancer progression and metastasis.Unrelated peripheral blood stem cell transplantation with 'megadoses' of purified CD34+ cells in three children with refractory severe aplastic anemia.Unrelated partially matched peripheral blood stem cell transplantation with highly purified CD34+ cells in a child with Wiskott-Aldrich syndrome.Chimeric protein for selective cell attachment onto cellulosic substrates.[Advances in research on circulating tumor cells in lung cancer].Combined positive and negative cell selection from allogeneic peripheral blood progenitor cells (PBPC) by use of immunomagnetic methods
P2860
Q24685690-04DA3ECB-08E7-429C-991F-D9B891A13BCFQ24792552-22D36082-EED2-41E6-8E65-D7B8369554A0Q30358229-6B855F5D-F8FC-473D-889A-2FC920AD7764Q33364616-64AFF388-7B8D-4411-86DF-19253D2A52E1Q33376375-7444CAC5-9B50-4C39-AFBA-32F9B2B60D95Q33878418-61ED43CB-DFF5-452F-983E-5FB59B93861FQ34022664-9E598B2B-AF8B-4BC9-A499-F54A9F4E58D3Q34066649-5BACF64E-5518-4B8D-9126-CE72C4401947Q35232853-C028886C-1413-48B7-92E9-30BBAE386A79Q36875730-7CAFE0DE-273C-4116-98F3-FC3EBE25E735Q37303777-C2E53335-108E-43B6-A3C2-7C133712F22CQ39052331-6819025A-E516-429A-B1AB-DD11DD99C487Q39531190-C21267BD-B92F-4B28-9676-11AD87834B1CQ39543319-BF825E7C-FD85-4CE6-8137-CCAD7A19383CQ40146395-EF504097-105F-45DE-A65F-C642E1398116Q55464514-6F45E912-A1C3-4F44-B743-C284E288D179Q57106803-6CFE00AD-0496-4E70-BEA7-DD535ED67F68
P2860
Large-scale isolation of CD34+ cells using the Amgen cell selection device results in high levels of purity and recovery.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Large-scale isolation of CD34+ ...... levels of purity and recovery.
@en
Large-scale isolation of CD34+ ...... levels of purity and recovery.
@nl
type
label
Large-scale isolation of CD34+ ...... levels of purity and recovery.
@en
Large-scale isolation of CD34+ ...... levels of purity and recovery.
@nl
prefLabel
Large-scale isolation of CD34+ ...... levels of purity and recovery.
@en
Large-scale isolation of CD34+ ...... levels of purity and recovery.
@nl
P2093
P356
P1476
Large-scale isolation of CD34+ ...... levels of purity and recovery.
@en
P2093
Briddell R
Miltenyi S
Recktenwald D
P356
10.1089/SCD.1.1997.6.5
P577
1997-02-01T00:00:00Z